论文部分内容阅读
目的探讨低分子肝素钙治疗老年重症肺炎伴糖尿病患者的临床疗效。方法选择住院诊治的老年重症肺炎伴糖尿病患者60例,随机分为观察组(31例)和对照组(29例),两组给予常规治疗,观察组在常规治疗的基础上加用低分子肝素钙,比较两组患者临床疗效。结果观察组临床总有效率明显高于对照组(P<0.05),治疗后各项检测指标较对照组明显改善(P<0.05),住院天数明显短于对照组(P<0.05),治疗后血浆D二聚体水平显著低于对照组。结论低分子肝素钙治疗老年重症肺炎伴糖尿病,能明显改善患者的症状体征及各项实验室指标,提高临床疗效。
Objective To investigate the clinical effect of low molecular weight heparin calcium in elderly patients with severe pneumonia with diabetes. Methods Sixty elderly patients with severe pneumonia and diabetes mellitus were selected and randomly divided into observation group (n = 31) and control group (n = 29). The two groups were given routine treatment. The observation group was given routine treatment with low molecular weight heparin Calcium, the clinical efficacy of two groups were compared. Results The total effective rate in the observation group was significantly higher than that in the control group (P <0.05). After the treatment, the detection indexes were significantly improved (P <0.05) and the days of hospitalization were significantly shorter than those in the control group (P <0.05) Plasma D dimer levels were significantly lower than the control group. Conclusion Low molecular weight heparin treatment of elderly patients with severe pneumonia with diabetes can significantly improve the patient’s symptoms and signs and laboratory indicators to improve clinical efficacy.